Nude mice were injected into the hind leg muscles with 5 × 105 shSCR, shTRF2, shSULF2 or shTRF2+SULF2 HCT116 cells/mouse. Tumors were measured in two dimensions using a caliper at the indicated time points and tumor weight was calculated using the formula: a × b2/2, where a and b are the long and short sizes of the tumor, respectively. Each experimental group included five mice.
Cd 1 male nude nu nu mice
The CD-1 male nude (nu/nu) mice are an immunodeficient mouse model. They are characterized by a lack of thymus-derived (T) lymphocytes due to a genetic mutation, resulting in a severely compromised immune system.
Lab products found in correlation
4 protocols using cd 1 male nude nu nu mice
Xenograft Tumor Growth Assay
Nude mice were injected into the hind leg muscles with 5 × 105 shSCR, shTRF2, shSULF2 or shTRF2+SULF2 HCT116 cells/mouse. Tumors were measured in two dimensions using a caliper at the indicated time points and tumor weight was calculated using the formula: a × b2/2, where a and b are the long and short sizes of the tumor, respectively. Each experimental group included five mice.
Intracardiac Metastasis Modeling in Nude Mice
For the intracardiac experimental metastasis model, nude mice (age 8–10 weeks) were anesthetized and injected with 2×106 cells of NRASQ61L (2/14, 2/17) or BRAFV600E (2/21, 2/33) clones, suspended in 100 μl sterile PBS, into the left ventricle of the heart by nonsurgical means. The spontaneous, pulsatile entrance of bright red oxygenated blood into the transparent needle hub indicated proper positioning of the needle. After 5 weeks, the mice were sacrificed; selected organs were excised from the mice at necropsy and were preserved in 10% formalin solution for subsequent scoring of metastasis. NRASQ61L (2/14, 2/17) and NRAS/Sema6A cells (2/14, and 2/17) were injected intracardially as above described, and after 7 weeks the mice were sacrificed and the organs were processed and analyzed as described above. Box plot of in vivo metastasis analysis was obtained by software Prism version 6.0.
Evaluation of Tumorigenic Ability in Mice
Antitumor Activity of Enzalutamide and 14d in Prostate Cancer
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!